Wright Investors Service’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,780
Closed -$567K 156
2024
Q2
$567K Buy
+1,780
New +$471K 0.15% 124
2016
Q2
Sell
-2,180
Closed -$243K 232
2016
Q1
$243K Sell
2,180
-548
-20% -$69.3K 0.1% 201
2015
Q4
$427K Buy
2,728
+736
+37% +$107K 0.16% 195
2015
Q3
$261K Sell
1,992
-2,639
-57% -$423K 0.12% 197
2015
Q2
$806K Hold
4,631
0.38% 80
2015
Q1
$799K Sell
4,631
-113
-2% -$17.2K 0.38% 89
2014
Q4
$614K Sell
4,744
-205
-4% -$26.4K 0.3% 113
2014
Q3
$637K Sell
4,949
-1,490
-23% -$154K 0.31% 101
2014
Q2
$570K Sell
6,439
-691
-10% -$66.5K 0.26% 123
2014
Q1
$670K Buy
7,130
+565
+9% +$57.8K 0.3% 115
2013
Q4
$742K Sell
6,565
-165
-2% -$14.9K 0.33% 99
2013
Q3
$531K Buy
6,730
+651
+11% +$47.6K 0.24% 133
2013
Q2
$400K Buy
+6,079
New +$392K 0.19% 153

Other funds holding UTHR

Wright Investors Service's UTHR Position: Q3 2024 in Review

Wright Investors Service sold out of United Therapeutics (UTHR) in Q3 2024, closing a stake of 1,780 shares — an estimated $567K sold.

Wright Investors Service first reported a position in UTHR in Q2 2013 and held it in 13 quarters. The position peaked at $806K in Q2 2015. 624 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • Wright Investors Service reported no remaining United Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Wright Investors Service sold 1,780 United Therapeutics shares in Q3 2024, an estimated $567K.
  • Wright Investors Service first reported a position in United Therapeutics in Q2 2013 and held it in 13 quarters.
  • Wright Investors Service's United Therapeutics position peaked at $806K in Q2 2015.
  • 624 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on Wright Investors Service's 13F filing for Q3 2024, filed 4 Oct 2024.